Kevin J. Corcoran

Kevin J. Corcoran

Auto-generated profile, based on publicly available information

Kevin J. Corcoran

Corcoran Consulting Group, San Bernardino, California

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2007 in Ophthalmology
Verified
Journal Article
Closed access
PRPradeep Y. Ramulu
Pradeep Y. Ramulu
KCKevin J. Corcoran
Kevin J. Corcoran
SCSuzanne L. Corcoran
Suzanne L. Corcoran
ARAlan L. Robin
Alan L. Robin

1 August 2015 in Ophthalmology
Verified
Journal Article
Closed access
KAKarun S. Arora
Karun S. Arora
ARAlan L. Robin
Alan L. Robin
KCKevin J. Corcoran
Kevin J. Corcoran
SCSuzanne L. Corcoran
Suzanne L. Corcoran
PRPradeep Ramulu
Pradeep Ramulu

11 October 2010 in Archives of Ophthalmology (1950)
Verified
Journal Article
Open access
PDF file
PRPradeep Y. Ramulu
Pradeep Y. Ramulu
DDDiana V. Do
Diana V. Do
KCKevin J. Corcoran
Kevin J. Corcoran
SCSuzanne L. Corcoran
Suzanne L. Corcoran
ARAlan L. Robin
Alan L. Robin
Retinal disease is highly prevalent among older individuals, and both age-related macular degeneration (AMD) and diabetic retinopathy account for more than half the irreversible blindness in older Americans.1-5 The prevalence of both macular degeneration and diabetic retinopathy increases with age, and the number of Americans affected by these conditions is expected to increase substantially as the number of Americans older than 65 years doubles from 2010 to 2040.6-8 Additionally, dietary and exercise habits are expected to increase the prevalence of diabetes mellitus within each age group.7,8 Thus, many more individuals with retinal diseases are expected to require treatment in future years.

30 January 2021 in Ophthalmology Glaucoma
Verified
Journal Article
Closed access
MBMichael V. Boland
Michael V. Boland
KCKevin J. Corcoran
Kevin J. Corcoran
ALAaron Y. Lee
Aaron Y. Lee

1 July 2015 in Current Opinion in Ophthalmology
Verified
Journal Article
Closed access
KCKevin J. Corcoran
Kevin J. Corcoran
This review examines the economic history of refractive surgery and the decline of laser-assisted in-situ keratomileusis (LASIK) in the USA, and the emergence of refractive cataract surgery as an area of growth. Since it peaked in 2007 at 1.4 million procedures per year, LASIK has declined 50% in the USA, whereas refractive cataract surgery, including presbyopia-correcting intraocular lenses (IOLs), astigmatism-correcting IOLs, and femtosecond laser-assisted cataract surgery, has grown to 350 000 procedures per year, beginning in 2003. Patients are price-sensitive and responsive to publicity (good or bad) about refractive surgery and refractive cataract surgery. LASIK's decline has been partially offset by the emergence of refractive cataract surgery. About 11% of all cataract surgery in the USA involves presbyopia-correcting IOLs, astigmatism-correcting IOLs, or a femtosecond laser. From the surgeon's perspective, there are high barriers to entry into the marketplace for refractive surgery and refractive cataract surgery due to the high capital cost of excimer and femtosecond lasers, the high skill level required to deliver spectacular results to demanding patients who pay out of pocket, and the necessity to perform a high volume of surgeries to satisfy both of these requirements. Probably, less than 7% of US cataract surgeons can readily meet all of these requirements.

1 September 1995 in Journal of Behavior Therapy and Experimental Psychiatry
Verified
Journal Article
Closed access
KCKevin J. Corcoran
Kevin J. Corcoran